CLINICAL TRIALS PROFILE FOR ETHIODIZED OIL
✉ Email this page to a colleague
All Clinical Trials for ETHIODIZED OIL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00870558 ↗ | Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer | Completed | Hospices Civils de Lyon | Phase 3 | 2005-06-01 | RATIONALE: Iodine I 131 ethiodized oil may help prevent or delay the recurrence of cancer. It is not yet known whether iodine I 131 ethiodized oil is more effective than non-radiolabeled ethiodized oil in preventing recurrent cancer in patients who have undergone treatment for liver cancer. PURPOSE: This randomized phase III trial is studying iodine I 131 ethiodized oil to see how well it works compared with non-radiolabeled ethiodized oil in preventing recurrent cancer in patients who have undergone treatment for liver cancer. |
| NCT03370575 ↗ | RCT of Ethiodized Poppyseed Oil VS the Second-generation Non-ionic Monomer Contrast in Hysterosalpingography of Infertile Patients. | Unknown status | Guangzhou Women and Children's Medical Center | Phase 4 | 2018-01-31 | This study evaluates the difference of imaging diagnostic quality and fertility promoting effect in the diagnosis and treatment of infertility by hysterosalpingography between using ethiodized poppyseed oil and the second-generation non-ionic monomer contrast. Half of participants will receive ethiodized poppyseed oil for hysterosalpingography, while the other half will receive the second-generation non-ionic monomer contrast for hysterosalpingography. |
| NCT04728633 ↗ | Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases | Recruiting | Thomas Jefferson University | Phase 2 | 2021-09-27 | This phase II trial studies the effect of transarterial chemoembolization in treating patients with uveal melanoma that has spread to the liver (liver metastases). Transarterial chemoembolization involves the injection of a blocking agent (gelatin sponge, ethiodized oil) and a chemotherapy agent (carmustine) directly into the artery in the liver to treat liver cancers. Chemotherapy drugs, such as carmustine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. transarterial chemoembolization with carmustine in combination with ethiodized oil and gelatin sponge may help cause the tumors in the liver to shrink or disappear. |
| NCT05490381 ↗ | Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes | Not yet recruiting | Guerbet | Phase 1 | 2022-12-01 | This phase I trial tests whether embolization done prior to surgery (preoperative) will improve surgical outcomes in head and neck tumors with large amounts of blood vessels (hypervascular). Embolization is a minimally invasive surgical technique performed under angiographic (imaging of blood vessels) guidance. Embolization therapy injects tiny particles into the arteries feeding tumors to cut off their blood supply which may help improve outcomes by preventing blood loss during surgery, reducing surgical times, and shrinking tumors or reducing recurrence. |
| NCT05490381 ↗ | Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes | Not yet recruiting | University of Washington | Phase 1 | 2022-12-01 | This phase I trial tests whether embolization done prior to surgery (preoperative) will improve surgical outcomes in head and neck tumors with large amounts of blood vessels (hypervascular). Embolization is a minimally invasive surgical technique performed under angiographic (imaging of blood vessels) guidance. Embolization therapy injects tiny particles into the arteries feeding tumors to cut off their blood supply which may help improve outcomes by preventing blood loss during surgery, reducing surgical times, and shrinking tumors or reducing recurrence. |
| NCT05672108 ↗ | Transarterial Chemoembolization for the Treatment of Lung Cancer | Not yet recruiting | National Cancer Institute (NCI) | Phase 2 | 2023-05-24 | This phase II trial evaluates how well transarterial chemoembolization (TACE) works in treating patients with non-small cell lung cancer. TACE involves the injection of a blocking agent (tris-acryl gelatin microspheres [embospheres]) and a chemotherapy agent (mitomycin) directly into the artery that supplies oxygen to lung tumors. Mitomycin works by inhibiting deoxyribonucleic acid synthesis. At the same time, the artery is blocked (embolized) with a blocking agent called tris-acryl gelatin microspheres (embospheres). This traps the chemotherapy inside the tumor and also cuts off the tumor's blood supply. As a result, the tumor is exposed to a high dose of chemotherapy, and is also deprived of nutrients and oxygen. An imaging agent called ethiodized oil (lipiodol) is also used during the procedure for help visualizing the tumor. TACE with mitomycin, lipiodol, and embospheres may be effective at controlling or stopping the growth of lung tumors. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ETHIODIZED OIL
Condition Name
| Condition Name for ETHIODIZED OIL | |
| Intervention | Trials |
| Metastatic Malignant Neoplasm in the Liver | 1 |
| Metastatic Uveal Melanoma | 1 |
| Pleural Neoplasm | 1 |
| Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for ETHIODIZED OIL
Trials by Country
Clinical Trial Progress for ETHIODIZED OIL
Clinical Trial Phase
Clinical Trial Sponsors for ETHIODIZED OIL
Sponsor Name
